PURA - Puration Reports First Revenue From Patented Cannabis Extraction And Progress Toward $3 Million Annual Revenue Target

Date : 05/18/2017 @ 8:10AM
Source :InvestorsHub NewsWire
Stock : Puration Inc. (PC) (PURA)
Quote : 0.0275  0.0015 (5.77%) @ 4:05PM

PURA - Puration Reports First Revenue From Patented Cannabis Extraction And Progress Toward $3 Million Annual Revenue Target


Dallas, Texas – May 18, 2017 -- InvestorsHub NewsWire -- – Puration, Inc. (USOTC: PURA) has published an online on demand earnings presentation reviewing the Company’s first quarter 2017 financial report.  In addition to a review of the most recent financial results, which highlights the Company’s first reported revenue from its patented cannabis extraction business, the report also includes details about the pending transaction with American Cannabis Innovations Conglomerated with specific mention that PURA stock will remain listed on the OTC Markets and will not be subject to a reverse split.  The report also includes details about the Company’s plans with NCM Biotech to pursue the development of cannabis pharmaceuticals.  Furthermore, the report includes the latest updates on the Companies three cannabis infused beverage contracts and its target $3 million in annual revenue.
 
REVIEW THE ENTIRE PURA EARNINGS REPORT
 
To learn more about Puration:                                                purationinc.com
To learn more about NCM Biotech:                                        ncmbiotech.com
 
Disclaimer/Safe Harbor: This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies’ contracts, the companies’ liquidity position, the companies’ ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.
 
Puration Contact:
Brian Shibley, CEO
info@purationinc.com
+1-214-937-9097
 

 

Puration Inc. (PC) (USOTC:PURA)
Historical Stock Chart

1 Year : From May 2016 to May 2017

Click Here for more Puration Inc. (PC) Charts.

Puration Inc. (PC) (USOTC:PURA)
Intraday Stock Chart

Today : Saturday 27 May 2017

Click Here for more Puration Inc. (PC) Charts.

Latest PURA Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.